CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...
Phase 3
Montreal, Quebec, Canada and 80 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Montreal, Quebec, Canada and 97 other locations
and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Montreal, Quebec, Canada and 139 other locations
of clinically significant exacerbations in participants with severe asthma with an eosinophilic phenotype. Throughout the study, all partici...
Phase 3
Greenfield Park, Quebec, Canada and 429 other locations
the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler in adults and adolescents with inadequately controlled asthma...
Phase 3
Montreal, Quebec, Canada and 180 other locations
decline in adult patients with uncontrolled moderate to severe asthma.The estimated duration is 4±1 weeks of screening and run-in period, fo...
Phase 4
Montreal, Quebec, Canada and 213 other locations
omalizumabTo evaluate the effect of dupilumab on asthma control at Week 24 compared to omalizumabTo evaluate the safety of dupilumab and om...
Phase 4
Montreal, Quebec, Canada and 94 other locations
A research study of how house dust mite tablets work compared to placebo in children aged between 5 and 11 years and who have allergy to house dust m...
Phase 3
Montréal, Canada and 116 other locations
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
Phase 3
Montreal, Quebec, Canada and 109 other locations
Clinical trials
Research sites
Resources
Legal